(1)
Risk Assessment of QT-Prolonging Drug Combinations and Their Association With QTc Interval Prolongation Among Psychiatric Patients: A Prospective Observational Study. Int. J. Res. Pharm. Sci. Technol. 2026, 9 (3). https://doi.org/10.33974/rveyrh87.